Search - tctmd.com

Displaying 41 - 60 of 65

Sort: Relevancy | Date

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Presentation TCTAP 2013

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Presenter: Adnan Kastrati

April 24, 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presentation TCT 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati

January 31, 2013

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Presentation TCT 2013

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Presenter: Salvatore Cassese, Gjin Ndrepepa, Lamin King, Tomohisa Tada, Massimiliano Fusaro, Adnan Kastrati

January 31, 2013

Restenosis after coronary stenting in 10,004 patients with follow-up angiography

Presentation TCT 2013

Restenosis after coronary stenting in 10,004 patients with follow-up angiography

Presenter: Salvatore Cassese, Robert Byrne, Julinda Mehilli, Stephanie Schulz, Tomohisa Tada, Lamin King, Susanne Pinieck, Albert Sch?mig, Adnan Kastrati

January 31, 2013

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Presentation TCT 2013

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Presenter: Tomohisa Tada, Adnan Kastrati, Robert Byrne, Tibor Schuster, Rezarta Cuni, Lamin King, Salvatore Cassese, Michael Joner, Steffen Massberg, Albert Sch?mig, Julinda Mehilli

January 31, 2013

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

Presentation TCT 2013

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

Presenter: Salvatore Cassese, Robert Byrne, Ilka Ott, Tareq Ibrahim, Tomohisa Tada, Lamin King, Adnan Kastrati, Massimiliano Fusaro

January 31, 2013

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

Final Judicial Sentence and Take-home Messages(4)

Presentation TCT 2012

Final Judicial Sentence and Take-home Messages(4)

Presenter: Adnan Kastrati

October 25, 2012

The Dos and Don'ts of Initiating Prospective Randomized Clinical Trials

Presentation TCT 2012

The Dos and Don'ts of Initiating Prospective Randomized Clinical Trials

Presenter: Adnan Kastrati

October 25, 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

ISAR-SAFE Update

Presentation TCT 2012

ISAR-SAFE Update

Presenter: Adnan Kastrati

October 22, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

October 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

October 19, 2012

News Daily News

Publicado el COMFORTABLE AMI: el DES con polímero biodegradable supera al SMD en STEMI

Yael L. Maxwell

August 23, 2012

News Daily News

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Yael L. Maxwell

August 23, 2012

News Daily News

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

March 23, 2012

News Daily News

BARC Criteria Validated Against Existing Bleeding Definitions

March 23, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

March 13, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.